Branhamella (Neisseria) catarrhalis was identified as a probable respiratory tract pathogen in seven patients, four with pneumonia and three with bronchitis.
In the past year, we have observed two characteristics of Branhamella (Neisseria) catarrhalis which have not been widely recognized. The first is the apparent capacity to produce acute respiratory infections in patients with chronic lung disease, and the second is the ability to produce ,8-lactamase. In seven patientsail of whom had underlying pulmonary pathology-bronchitis or pneumonia was documented by clinical presentation, roentgenographic findings, and sputum examination. We used one method for plasmid extraction and found no plasmid deoxyribonucleic acid in the j3-lactamase-positive or -negative strains of B. catarrhalis.
CASE REPORTS Patient 1. Patient 1 was a 53-year-old man admitted 19 April 1978 with fever and an acute episode of wheezing following aspiration. In the past, the patient had undergone surgery for a giant hiatal hernia and now had an intrathoracic stomach. Recurrent jf-Lactamase was detected by a modification of the chromogenic cephalosporin procedure (11) . Penicillin susceptibility was tested by the standardized disk diffusion method. For two of the fi-lactamase-producing strains, susceptibility to penicillin was also tested by a broth dilution procedure utilizing inocula of 104 and 106 colony-forming units per ml.
To screen for the presence of extrachromosomal deoxyribonucleic acid, B. catarrhalis was grown overnight in the presence of penicillin (1 ug/ml). Ethanolprecipitated deoxyribonucleic acid was prepared in duplicate from cleared lysates and was electrophoresed in a 0.7% agarose gel as described by Meyers et al. (10 Of the seven isolates of B. catarrhalis, five were found to produce ,B-lactamase. Penicillin resistance, as determined by the standardized disk diffusion method, correlated in all instances with the production of ,B-lactamase. For the two ,B-lactamase-producing strains which were tested by the broth dilution procedure, the minimal inhibitory concentrations for penicillin were 25 and 12 ,ug/ml, respectively, with an inoculum of 104 colony-forming units per ml, and 100 and 25 ,ug/mI, respectively, with an inoculum of 106 colony-forming units per ml.
No plasmid deoxyribonucleic acid could be detected in eitherfl-lactamase-positive or -negative strains grown in broth or on agar containmg penicillin.
Cliical data. Four of the patients from whom B. catarrhalis was isolated had pneumonia documented by chest roentgenography. The remaining three had acute bronchitis, defined as an increase in cough with production of large amounts of purulent sputum. Clinical data on all the patients are presented in Table 1 . Patients 1 and 3 are presented as illustrative cases.
DISCUSSION
The recognition of B. catarrhalis as a possible pathogen in our patients prompted a review of the literature. B. catarrhalis has been isolated from middle ear aspirates in a small percentage of children with otitis media (7) . Sporadic cases of meningitis (3, 4) , endocarditis (14) , urethritis (8) , and bacteremia with and without purpura fuihninans (1, 5) have also been reported. To our knowledge, only one patient with B. catarrhalis pulmonary infection has been previously reported from the United States (9). This patient was immunosuppressed, and he died from overwhelming B. catarrhalis pneumonia.
The role of B. catarrhalis in pulmonary infections has been demonstrated best by Ninane and colleagues in Belgium (12) . These investigators performed transtracheal aspiration on retired coal miners with acute bronchitis and chronic lung disease. B. catarrhalis, in pure culture, was the third most common isolate from these patients. (Haemophilus influenza and S. pneumoniae were isolated more frequently.) B. catarrhalis was also isolated in combination with H. influenza in one patient. Of particular interest is the fact that one patient had f)-lactamaseproducing B. catarrhalis with a minimal inhibitory concentration of ampicillin of 16 ,g/mI. This patient failed to respond to ampicillin, but he improved rapidly when treated with cefuroxime (minimal inhibitory concentration, 2 ug/ml). Ninane et al. reported another anthracosilicotic coal miner with acute bronchitis who had f8-lactamase-producing B. catarrhalis grown in pure culture from a transtracheal aspirate (13) . This patient responded to therapy with amoxicillin combined with clavulanic acid, a ,B-lactamase inhibitor.
All seven of our patients whose sputum yielded B. catarrhalis as the predominant organism had some underlying lung pathology. Most of these patients had received ampicillin or penicillin intermittently for past pulmonary infections. The finding of several ,B-lactamaseproducing B. catarrhalis strains in this patient population may be related to this prior antibiotic usage; we postulate that prior penicillin use may have allowed selection of a resistant population VOL. 13, 1981 on October 25, 2017 by guest http://jcm.asm.org/ Downloaded from 
